Results 131 to 140 of about 13,652 (256)
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel +5 more
wiley +1 more source
ADCY5-related dyskinesias: An amalgamation of various hyperkinetic movement disorders
Adenylyl cyclase 5 (ADCY5)-related dyskinesia is a rare disorder characterized by early-onset paroxysmal choreoathetosis, dystonia, myoclonus, or a combination thereof, primarily involving the limbs, face, and neck.
Dinesh Khandelwal +3 more
doaj +1 more source
Chewing-induced Facial Dystonia
Sam SY Yang +2 more
openaire +1 more source
Abstract Aim To qualitatively assess the causes, adaptations, and psychosocial impact of falls, and solutions for safer environments, as shared by individuals diagnosed with cerebral palsy (CP). Method Ambulatory adults with CP (n = 165; age median [interquartile range], range: 30 years [25–50], 18–76 years); 101 females, 59 males, five non‐binary/not ...
Marissa Esterley +6 more
wiley +1 more source
Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.70070 Abstract Aim To identify the outcomes and standardized tools used to measure changes following telehealth‐delivered physical therapy interventions in children and young people with cerebral palsy, within the framework of the International Classification of Functioning ...
Isabella S. Christovão +6 more
wiley +1 more source
Two Cases of SPEN Haploinsufficiency Presenting with Dystonia: Expanding the Genotype and Phenotype
Movement Disorders Clinical Practice, EarlyView.
Lisa Buikema +5 more
wiley +1 more source
Patient outcomes in KCNQ2 developmental and epileptic encephalopathy
Abstract The aim of this study was to review and summarize the literature describing clinically observed or caregiver‐reported and patient‐reported KCNQ2 developmental and epileptic encephalopathy (DEE) outcomes. Three online databases and selected congress proceedings were searched (August 2023).
Grant Maclaine +9 more
wiley +1 more source
Chemodenervation for the Treatment of Facial Dystonia [PDF]
Jurij R. Bilyk +4 more
openaire +1 more source
Hallervorden spatz disease – a rare clinicoradiological diagnosis [PDF]
Hallervorden Spatz disease, also known as pantothenate kinase associated neuro-degeneration, is a rare, progressive neurological disorder usually seen in first decade of life.
A Khan, Ejaz +2 more
core +1 more source
Movement Disorders Clinical Practice, EarlyView.
Luca Angelini, Rick C.G. Helmich
wiley +1 more source

